CASSIOPE

Research code: CASSIOPE
Research name: Prospective, non-interventional study with cabozantinib tablets for the treatment of advanced renal cell carcinoma (RCC) in adult patients with prior vascular endothelial growth factor (VEGF)-targeted therapy.
Indication: renal cell carcinoma
Principal researcher: Ewa Chmielowska, MD, PhD